The news is by your side.
Browsing Tag


Roche CEO says new drugs will offset biosimilar incursions

7 months, 3 days ago
ZURICH: Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals’ copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.…

Roche’s emicizumab haemophilia drug succeeds in trial

1 year, 9 months ago
SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday. Roche is hoping to win a slice of the $11 billion-a-year haemophilia drug market with…

Roche lung cancer drug success adds to pressure on Bristol

2 years, 7 days ago
COPENHAGEN: Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb's dominant position in the field. The…